TY - JOUR AU - Durie, B. G. AU - Salmon, S. E. PY - 1975 DA - 1975// TI - A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival JO - Cancer VL - 36 UR - https://doi.org/3.0.CO;2-U DO - 3.0.CO;2-U ID - Durie1975 ER - TY - JOUR AU - Kyrtsonis, M. -. C. AU - Maltezas, D. AU - Tzenou, T. AU - Koulieris, E. AU - Bradwell, A. R. PY - 2009 DA - 2009// TI - Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma JO - Semin Hematol VL - 46 UR - https://doi.org/10.1053/j.seminhematol.2009.02.004 DO - 10.1053/j.seminhematol.2009.02.004 ID - Kyrtsonis2009 ER - TY - JOUR AU - Alexanian, R. PY - 1977 DA - 1977// TI - Blood volume in monoclonal gammopathy JO - Blood VL - 49 ID - Alexanian1977 ER - TY - JOUR AU - Kim, J. AU - Hayton, W. AU - Robinson, J. AU - Anderson, C. PY - 2007 DA - 2007// TI - Kinetics of FcRn-mediated recycling of IgG and albumin in humans: Pathophysiology and therapeutic implications using a simplified mechanism-based model JO - Clin Immunol VL - 122 UR - https://doi.org/10.1016/j.clim.2006.09.001 DO - 10.1016/j.clim.2006.09.001 ID - Kim2007 ER - TY - JOUR AU - Wines, B. D. AU - Hogarth, P. M. PY - 2006 DA - 2006// TI - IgA receptors in health and disease JO - Tissue Antigens VL - 68 UR - https://doi.org/10.1111/j.1399-0039.2006.00613.x DO - 10.1111/j.1399-0039.2006.00613.x ID - Wines2006 ER - TY - JOUR AU - Bradwell, A. R. AU - Harding, S. J. AU - Fourrier, N. J. AU - Wallis, G. AU - Drayson, M. AU - Hugh, D. PY - 2009 DA - 2009// TI - Assessment of monoclonal gammopathies by nephelometric measurements of individual immunoglobulin κ/λ ratios JO - Clin Chem VL - 55 UR - https://doi.org/10.1373/clinchem.2009.123828 DO - 10.1373/clinchem.2009.123828 ID - Bradwell2009 ER - TY - BOOK AU - Bradwell, A. R. PY - 2010 DA - 2010// TI - Serum Free Light Chain Analysis (Plus Hevylite) PB - The Binding Site Ltd CY - Birmingham, UK ID - Bradwell2010 ER - TY - JOUR AU - Keren, D. F. PY - 2009 DA - 2009// TI - Heavy/Light-Chain Analysis of monoclonal gammopathies JO - Clin Chem VL - 55 UR - https://doi.org/10.1373/clinchem.2009.132753 DO - 10.1373/clinchem.2009.132753 ID - Keren2009 ER - TY - JOUR AU - Greipp, P. R. AU - San Miguel, J. AU - Durie, B. G. PY - 2005 DA - 2005// TI - International staging system for multiple myeloma JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2005.04.242 DO - 10.1200/JCO.2005.04.242 ID - Greipp2005 ER - TY - JOUR AU - Avet-Loiseau, H. AU - Harousseau, J. L. AU - Moreau, P. AU - Mathiot, C. AU - Facon, T. AU - Attal, M. PY - 2009 DA - 2009// TI - Heavy/light chain specific ratios at presentation are prognostic for progression-free survival in the IFM 2005-01 myeloma trial. [Abstract] JO - Blood VL - 114 ID - Avet-Loiseau2009 ER - TY - JOUR AU - Avet-Loiseau, H. AU - Mirbahai, L. AU - Harousseau, J. L. AU - Moreau, P. AU - Mathiot, C. AU - Facon, T. PY - 2010 DA - 2010// TI - Serum immunoglobulin heavy/light chain ratios are independant risk factors for predicting progression free survival in multiple myeloma. [Abstract] JO - Heamatologica VL - 95 ID - Avet-Loiseau2010 ER - TY - JOUR AU - Perosa, F. AU - Minoja, C. AU - Favoino, E. AU - Prete, M. AU - Dammaco, F. PY - 2010 DA - 2010// TI - Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count JO - Blood Cells Mol Dis VL - 42 UR - https://doi.org/10.1016/j.bcmd.2008.09.003 DO - 10.1016/j.bcmd.2008.09.003 ID - Perosa2010 ER - TY - JOUR AU - Ayliffe, M. J. AU - Davies, F. E. AU - Castro, D. AU - Morgan, G. PY - 2007 DA - 2007// TI - Demonstration of changes in plasma cell subsets in multiple myeloma JO - Haematologica VL - 92 UR - https://doi.org/10.3324/haematol.11133 DO - 10.3324/haematol.11133 ID - Ayliffe2007 ER - TY - JOUR AU - Kyrtsonis, M. C. AU - Vassilakopoulos, T. P. AU - Kafasi, N. AU - Sachanas, S. AU - Tzenou, T. AU - Papadogiannis, A. AU - Galanis, Z. PY - 2007 DA - 2007// TI - Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma JO - Br J Haematol VL - 137 UR - https://doi.org/10.1111/j.1365-2141.2007.06561.x DO - 10.1111/j.1365-2141.2007.06561.x ID - Kyrtsonis2007 ER - TY - JOUR AU - Bettini, R. AU - Redaelli, S. AU - Maino, C. AU - Bertuol, S. AU - Costantini, C. AU - Lazzarini, A. PY - 2005 DA - 2005// TI - Prognostic value of serum beta-2 microglobulin in multiple myeloma JO - Recent Prog Med VL - 96 ID - Bettini2005 ER - TY - JOUR AU - Simonsson, B. AU - Kallander, C. F. AU - Brenning, G. AU - Killander, A. AU - Gronowitz, J. S. AU - Bergstrom, R. PY - 1988 DA - 1988// TI - Biochemical markers in multiple myeloma: a multivariate analysis JO - J Haematol VL - 69 UR - https://doi.org/10.1111/j.1365-2141.1988.tb07601.x DO - 10.1111/j.1365-2141.1988.tb07601.x ID - Simonsson1988 ER - TY - JOUR AU - Cavo, M. AU - Galieni, P. AU - Zuffa, E. AU - Baccarani, M. AU - Gobbi, M. AU - Tura, S. PY - 1989 DA - 1989// TI - Prognostic variables and clinical staging in multiple myeloma JO - Blood VL - 74 ID - Cavo1989 ER - TY - JOUR AU - Eleuterakis-Papaiakovou, V. AU - Bamias, A. AU - Gika, D. AU - Simeonidis, A. AU - Pouli, A. AU - Anagnostopoulos, A. PY - 2007 DA - 2007// TI - Renal failure in multiple myeloma: incidence, correlations and prognostic significance JO - Leuk Lymphoma VL - 48 UR - https://doi.org/10.1080/10428190601126602 DO - 10.1080/10428190601126602 ID - Eleuterakis-Papaiakovou2007 ER -